Moderna
MRNA
#1079
Rank
$18.02 B
Marketcap
$46.83
Share price
-6.86%
Change (1 day)
-33.15%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Moderna (MRNA) - Net assets

Net assets on the balance sheet as of June 2024 : $11.71 Billion USD

According to Moderna 's latest financial reports the company has $11.71 Billion USD in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Moderna - Net assets on balance sheet (from 2017 to 2024)

Net assets by year

Year Net assets Change
2023-12-31$$13.85 B-27.55%
2022-12-31$$19.12 B35.19%
2021-12-31$$14.14 B452.32%
2020-12-31$$2.56 B117.99%
2019-12-31$$1.17 B-23.23%
2018-12-31$$1.53 B144.72%
2017-12-31$$0.62 B-25.72%
2016-12-31$$0.84 B

Net assets for similar companies or competitors

Company Net assets differencediff. Country
$98.18 M-99.16%๐Ÿ‡บ๐Ÿ‡ธ USA
$43.64 B 272.68%๐Ÿ‡บ๐Ÿ‡ธ USA
-$36.4 Million-100.31%๐Ÿ‡บ๐Ÿ‡ธ USA
$32.35 M-99.72%๐Ÿ‡บ๐Ÿ‡ธ USA
$43.44 B 270.91%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
$0.33 B-97.11%๐Ÿ‡บ๐Ÿ‡ธ USA
$70.15 B 499.03%๐Ÿ‡บ๐Ÿ‡ธ USA